BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30302943)

  • 21. The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool.
    Carel K; Bratton DL; Miyazawa N; Gyorkos E; Kelsay K; Bender B; Strand M; Atkins D; Gelfand EW; Klinnert MD
    Ann Allergy Asthma Immunol; 2008 Nov; 101(5):500-7. PubMed ID: 19055204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis.
    Hachisuka J; Takeuchi S; Kido M; Fukiwake N; Furue M
    Int J Dermatol; 2009 Apr; 48(4):374-8. PubMed ID: 19335422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Objective evaluation for severity of atopic dermatitis by morphologic study of skin surface contours.
    Son SW; Park SY; Ha SH; Park GM; Kim MG; Moon JS; Yoo DS; Oh CH
    Skin Res Technol; 2005 Nov; 11(4):272-80. PubMed ID: 16221144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between Objective SCORAD and Three-Item Severity Score used by physicians and Objective PO-SCORAD used by parents/patients in children with atopic dermatitis.
    van Oosterhout M; Janmohamed SR; Spierings M; Hiddinga J; de Waard-van der Spek FB; Oranje AP
    Dermatology; 2015; 230(2):105-12. PubMed ID: 25660989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory and severity evaluation of pediatric atopic dermatitis and moisturizer response in different phenotypes.
    Batmaz SB
    Allergol Immunopathol (Madr); 2018; 46(6):571-577. PubMed ID: 29980402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are quality of family life and disease severity related in childhood atopic dermatitis?
    Ben-Gashir MA; Seed PT; Hay RJ
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):455-62. PubMed ID: 12428837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of synbiotic supplementation on children with atopic dermatitis: an observational prospective study.
    Ibáñez MD; Rodríguez Del Río P; González-Segura Alsina D; Villegas Iglesias V
    Eur J Pediatr; 2018 Dec; 177(12):1851-1858. PubMed ID: 30259127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
    Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
    J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of skin barrier impairment in atopic dermatitis with aeroallergen sensitization.
    De Marchi F; Piacentini GL; Piazza M; Sandri M; Boner AL; Peroni DG
    Allergy Asthma Proc; 2015; 36(6):e127-33. PubMed ID: 26534744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage migration inhibitory factor (MIF) in the stratum corneum: a marker of the local severity of atopic dermatitis.
    Yasuda C; Enomoto A; Ishiwatari S; Mori N; Kagoyama K; Matsunaga K; Yoshihisa Y; Matsukuma S; Shimizu T
    Exp Dermatol; 2014 Oct; 23(10):764-6. PubMed ID: 25056219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance P restores normal skin architecture and reduces epidermal infiltration of sensory nerve fiber in TNCB-induced atopic dermatitis-like lesions in NC/Nga mice.
    Choi H; Kim DJ; Nam S; Lim S; Hwang JS; Park KS; Hong HS; Won Y; Shin MK; Chung E; Son Y
    J Dermatol Sci; 2018 Mar; 89(3):248-257. PubMed ID: 29269174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
    Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
    Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe.
    Stalder JF; Barbarot S; Wollenberg A; Holm EA; De Raeve L; Seidenari S; Oranje A; Deleuran M; Cambazard F; Svensson A; Simon D; Benfeldt E; Reunala T; Mazereeuv J; Boralevi F; Kunz B; Misery L; Mortz CG; Darsow U; Gelmetti C; Diepgen T; Ring J; Moehrenschlager M; Gieler U; Taïeb A;
    Allergy; 2011 Aug; 66(8):1114-21. PubMed ID: 21414011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury.
    Harder J; Dressel S; Wittersheim M; Cordes J; Meyer-Hoffert U; Mrowietz U; Fölster-Holst R; Proksch E; Schröder JM; Schwarz T; Gläser R
    J Invest Dermatol; 2010 May; 130(5):1355-64. PubMed ID: 20107483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis.
    Hon KL; Wong KY; Leung TF; Chow CM; Ng PC
    Am J Clin Dermatol; 2008; 9(1):45-50. PubMed ID: 18092843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.
    Esaki H; Ewald DA; Ungar B; Rozenblit M; Zheng X; Xu H; Estrada YD; Peng X; Mitsui H; Litman T; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Jan; 135(1):153-63. PubMed ID: 25567045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Langerhans cell hyperplasia and IgE expression in canine atopic dermatitis.
    Olivry T; Moore PF; Affolter VK; Naydan DK
    Arch Dermatol Res; 1996 Sep; 288(10):579-85. PubMed ID: 8919040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity scoring of atopic dermatitis: a comparison of two scoring systems.
    Rullo VE; Segato A; Kirsh A; Sole D
    Allergol Immunopathol (Madr); 2008; 36(4):205-11. PubMed ID: 18928687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Fractalkine (CX3CL1) Concentration Correlates with Clinical Severity in Pediatric Atopic Dermatitis Patients.
    Chong S; Lan H; Zeng K; Zhao X
    Ann Clin Lab Sci; 2016; 46(2):168-73. PubMed ID: 27098623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis.
    Gu CY; Gu L; Dou X
    Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.